• Phil Baran on the Quest to Make Chemistry Boring Again

    Sep 3, 2020, 01:10 AM by Michael Croft
    Bio-IT World | Phil Baran of Scripps Research is dedicated to simplifying chemical synthesis, not to create techniques that are “gimmicky” but will instead become the standard processes of the future. Maybe, “fifty years from now,” he predicts, “we’ll look back in curiosity at chemists of our age who had stages in their syntheses instead of making everything in 1-3 steps.”
    Full story
  • Truth Challenge v2: Latest Challenge Results From Genome In A Bottle

    Sep 2, 2020, 13:30 PM by Michael Croft
    Bio-IT World  PrecisionFDA and The Genome in a Bottle (GIAB) consortium have announced the results of the Truth Challenge V2: Calling Variants from Short and Long Reads in Difficult-to-Map Regions such as segmental duplications, and the Major Histocompatibility Complex (MHC).
    Full story
  • Senior team at healthcare agency Page & Page become Partners

    Sep 2, 2020, 10:53 AM by Michael Croft
    LONDON, UNITED KINGDOM - Sep 2, 2020 - Senior team at healthcare agency Page & Page become Partners Significant changes at Page & Page and Partners also include a new London office, a series of client wins and company growth during Covid  London, UKx
    Full story
  • AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Primary tabs

    Sep 2, 2020, 05:23 AM by Michael Croft
    EDINBURGH, UNITED KINGDOM - Sep 2, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, announces the award of a £1
    Full story
  • FamHis, Inc. Completes its Launch of the FamGenix Family Health History Platform

    Sep 1, 2020, 14:33 PM by Michael Croft
    BOYNTON BEACH, FL - Sep 1, 2020 - FamHis, Inc. announces the completion and worldwide release of their next-generation family health history platform FamGenix
    Full story
  • A Virtual Feast: A Preview of Bio-IT World 2020

    Sep 1, 2020, 13:55 PM by Michael Croft
    Bio-IT World | The 2020 Bio-IT World Conference & Expo Virtual includes three days full of content, networking, and interaction across 16 tracks, plenary session, workshops, posters, awards, and happy hours. And for the first time ever, many presentations will be available on demand after their first showing. We are already building our agenda.  

     
Full story
  • CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management

    Sep 1, 2020, 11:08 AM by Michael Croft
    LOUVAIN-LA-NUEVE, BELGIUM - Sep 1, 2020 - CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management
    Full story
  • Racial Impacts of COVID-19, Neutralizing Antibodies, More

    Aug 28, 2020, 10:05 AM by Michael Croft

    Bio-IT World | Racial segregation of COVID-19 is following HIV patterns, more data on neutralizing antibodies, four months of data from Italy's use of hydroxychloroquine, and a computer model for school launches. Plus, an award from the UK government for vaccine development. 

    Full story
  • CD Genomics Introduces Extended Panels for SARS-CoV-2 Detection and Research

    Aug 28, 2020, 01:42 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Aug 28, 2020 - CD Genomics, a leader in sequencing, microarray analysis, library construction and genotyping, recently announced availability of its CDAMP® SARS-CoV-2 Panel Kit, CDCAP® β-CoVs Panel Kit and CDCAP® Respiratory Virus Panel Kit for SARS-CoV-2 detection and research via its predesigend NGS panels
    Full story
  • UK Biobank Contracts With DNAnexus, AWS to Build Data Analysis Platform

    Aug 26, 2020, 14:40 PM by Michael Croft
    Bio-IT World  UK Biobank, a long-term study of health data from 500,000 UK volunteers, announced today that it is developing its own cloud-based Data Analysis Platform to make its extensive medical data available to a broader range of researchers around the world. Funding for the Data Analysis Platform has come from Wellcome, and it will be developed over the next three years by DNAnexus in collaboration with Amazon Web Services (AWS).
    Full story
  • Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners

    Aug 26, 2020, 10:49 AM by Michael Croft
    PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners
    Full story
  • Vertiv, Pure Storage, And More: News From August 2020

    Aug 25, 2020, 15:15 PM by Michael Croft
    Bio-IT World   August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Vertiv, Pure Storage, and more.
    Full story
  • Aveshka announces Dr. Til Jolly as Chief Medical Officer

    Aug 21, 2020, 21:24 PM by Michael Croft
    WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the company’s executive team in the newly created role of Chief Medical Officer (CMO)
    Full story
  • Beetle Viruses, Nitrate Supplements, Missing Sense of Smell: COVID-19 Updates

    Aug 21, 2020, 09:35 AM by Michael Croft
    Bio-IT World | How a beetle virus is informing SARS-CoV-2 research, plus nitrate supplementation for aid breathing, new small molecules active against the virus, and a theory for why COVID-19 patients lose their sense of smell. Plus, $9.8 million from DOD for vaccine research and virus-like particles for vaccine development.
    Full story
  • The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry

    Aug 20, 2020, 23:49 PM by Michael Croft
    NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management
    Full story
  • AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment

    Aug 20, 2020, 23:36 PM by Michael Croft
    NY, NY - Aug 20, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database
    Full story
  • InSysBio to present the new version of Immune Response Template

    Aug 20, 2020, 10:41 AM by Michael Croft
    MOSCOW, RUSSIA - Aug 20, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents the new version of its Immune Response Template (IRT)
    Full story
  • Combined Monogenic, Polygenic Risk Scores Could Change Medical Understanding of Disease

    Aug 20, 2020, 08:20 AM by User Not Found
    Bio-IT World | In a paper published today in Nature Communications, IBM and the Broad Institute reported the first results of their collaboration to develop predictive models for cardiovascular disease.
    Full story
  • Rho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free Webinar

    Aug 19, 2020, 16:53 PM by Michael Croft
    DURHAM, NC, US - Aug 20, 2020 - MEDIA ADVISORYRho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free WebinarCRO shares best practices and solutions to help sponsors get the most out of their hybrid, virtual and synthetic clinical trials  WHAT:                 Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will discuss its approach to and solutions for maximizing the benefits of decentralized clinical trials in an upcoming webinar, "CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials
    Full story
  • Lyniate and PatientPing Form Strategic Partnership to Ensure Compliance with the CMS E-Notifications Requirements

    Aug 19, 2020, 09:14 AM by Michael Croft
    BOSTON, MA - Aug 19, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced a partnership with PatientPing, the nation’s most comprehensive care collaboration platform, to develop a connector solution that provides the IT infrastructure necessary to support seamless integration of e-notification data for admissions, discharges, and transfers (ADT)
    Full story